Skip to content

Newsroom

type
year
Illustration image.png

Orion comments on ANDA filed by Wockhardt Limited for a generic version of Orion's proprietary drug Stalevo® (25/200/100; 37.5/200/150 and 50/200/200 mg strengths) in the United States

12/11/2008 Stock exchange release
Illustration image.png

Orion sues Wockhardt USA, Inc. and Wockhardt Limited in the U.S. to enforce Orion's U.S. Patents covering its proprietary drug Stalevo®

12/8/2008 Stock exchange release
Illustration image.png

Orion to renew operational model of pharmaceutical R&D. Negotiation proposal on reduction of up to 300 employees in Finland

11/19/2008 Stock exchange release
Illustration image.png

Orion sues Sun Pharma Global, Inc. in the U.S. to enforce Orion's U.S. Patent No. 5,446,194 covering its proprietary drug Comtan®

11/12/2008 Stock exchange release
Illustration image.png

Orion sues Sun Pharma Global, Inc. in the U.S. to enforce Orion's U.S. Patent No. 5,446,194 covering its proprietary drug Comtan®

11/12/2008 Stock exchange release
Illustration image.png

Orion comments on ANDA filed by Wockhardt Limited for a generic version of Orion's proprietary drug Stalevo® in the United States

11/3/2008 Stock exchange release
Illustration image.png

Composition of the Nomination Committee of Orion Corporation

10/29/2008 Stock exchange release
Illustration image.png

Orion Corporation's publication schedules for financial reporting in 2009

10/28/2008 Stock exchange release
Illustration image.png

Orion Group Interim Report 1-9/2008

10/28/2008 Stock exchange release
Illustration image.png

Orion comments on new ANDA by Sun Pharma Global, Inc. for generic entacapone (Orion's proprietary drug Comtan®) in the United States

10/7/2008 Stock exchange release
Illustration image.png

Orion updates progress with dexmedetomidine trials

9/12/2008 Stock exchange release
Illustration image.png

Orion Group Interim Report 1-6/2008

8/5/2008 Stock exchange release
Illustration image.png

Orion Corporation publishes Interim Report Q2/2008 on 5 August 2008

7/23/2008 Stock exchange release
Illustration image.png

Orion's marketing rights for Paclical® Vet (paclitaxel) expanded European-wide

6/25/2008 Press release
Illustration image.png

Orion receives rights for incontinence drug Kentera® from Recordati

5/30/2008 Press release
Illustration image.png

Orion has decided not to continue the development of a new COMT inhibitor candidate

5/9/2008 Stock exchange release
Illustration image.png

Orion Group Interim Report 1-3/2008

4/25/2008 Stock exchange release
Illustration image.png

Orion seeking broader indication for Stalevo

4/15/2008 Stock exchange release